Nonalcoholic Steatohepatitis Clinical Trials in Oklahoma City, Oklahoma
3 recruitingOklahoma City, Oklahoma
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
Target PharmaSolutions, Inc.15,000 enrolled74 locationsNCT02815891
Recruiting
Not Applicable
Metabolic Pathology of Pediatric NAFLD
ObesityNonalcoholic SteatohepatitisNonalcoholic Fatty Liver
University of Oklahoma100 enrolled1 locationNCT05430178